Time-dependent changes in non-COX-1-dependent platelet function with daily aspirin therapy

Details

• Alternative Title:
  J Thromb Thrombolysis
• Personal Author:
  Voora, Deepak ; Ortel, Thomas L. ; Lucas, Joseph E. ; Chi, Jen-Tsan ; Becker, Richard C. ; Ginsburg, Geoffrey S.
• Description:
  Objectives
  
  To develop an integrated metric of non COX-1 dependent platelet function (NCDPF) to measure the temporal response to aspirin in healthy volunteers and diabetics.
  
  Background
  
  NCDPF on aspirin demonstrates wide variability, despite suppression of COX-1. Although a variety of NCDPF assays are available, no standard exists and their reproducibility is not established.
  
  Methods
  
  We administered 325mg/day aspirin to two cohorts of volunteers (HV1, n = 52, and HV2, n = 96) and diabetics (DM, n = 74) and measured NCDPF using epinephrine, collagen, and ADP aggregometry and PFA100 (collagen/epi) before (Pre), after one dose (Post), and after several weeks (Final). COX-1 activity was assessed with arachidonic acid aggregometry (AAA). The primary outcome of the study, the platelet function score (PFS), was derived from a principal components analysis of NCDPF measures.
  
  Results
  
  The PFS strongly correlated with each measure of NCDPF in each cohort. After two or four weeks of daily aspirin the Final PFS strongly correlated (r > 0.7, p<0.0001) and was higher (p < 0.01) than the Post PFS. The magnitude and direction of the change in PFS (Final - Post) in an individual subject was moderately inversely proportional to the Post PFS in HV1 (r = −0.45), HV2 (r = −0.54), DM (r = −0.68), p<0.0001 for all. AAA remained suppressed during aspirin therapy.
  
  Conclusions
  
  The PFS summarizes multiple measures of NCDPF. Despite suppression of COX-1 activity, NCDPF during aspirin therapy is predictably dynamic: those with heightened NCDPF continue to decline whereas those with low/normal NCDPF return to pre-aspirin levels over time.
  
  
• Subjects:
  Adult Aged Aspirin Blood Platelets Cohort Studies Cyclooxygenase 1 Drug Administration Schedule Female Humans Male Middle Aged Pilot Projects Platelet Function Tests Time Factors Young Adult

  More +
• Source:
  J Thromb Thrombolysis. 33(3):246-257.
• Pubmed ID:
  22294277
• Pubmed Central ID:
  PMC3337886
• Document Type:
  Journal Article
• Funding:
  5RC1GM091083/GM/NIGMS NIH HHS/United States ; 5T32HL007101/HL/NHLBI NIH HHS/United States ; 5U01DD000014-06/DD/NCBDD CDC HHS/United States ; 5UL1RR024128/RR/NCRR NIH HHS/United States ; RC1 GM091083/GM/NIGMS NIH HHS/United States ; RC1 GM091083-02/GM/NIGMS NIH HHS/United States
• Volume:
  33
• Issue:
  3
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:4decbf12614a97c439772f08846b6daac69301403cfcdf4d916c0fdc1244082b
• Download URL:
  https://stacks.cdc.gov/view/cdc/33352/cdc_33352_DS1.pdf
• File Type:
  [PDF - 1.19 MB ]